On January 6, 2025, Israel’s Gilat Satellite Networks, which develops, manufactures, and markets ground-based satellite systems for in-flight connectivity, completed its acquisition of U.S.-based Stellar Blu, a provider of avionics solutions and satellite communications terminals. In an exclusive interview with Kursiv.Investments, Gilat CFO Gil Benyamini explained the significance of the…
On Wednesday, January 8, shares of plant-based energy drink producer Yerbaé Brands Corp spiked more than 20% to hit a four-month high following the announcement of its acquisition by U.S.-based beverage maker Safety Shot. Meanwhile, Safety Shot stock plummeted following the news. The transaction values Yerbaé at more than $15…
The stock price of Sana Biotechnology surged 160% on January 8, with intraday gains exceeding 300%. The company announced a groundbreaking achievement: successfully transplanting insulin-producing pancreatic cells into a patient with type 1 diabetes without the need for immunosuppression. Sana hopes this breakthrough will revolutionize the nearly $100 billion diabetes…
On Tuesday, January 7, shares of small cancer drug developer MAIA Biotechnology jumped more than 15% to hit their highest level in a month and a half as investors rushed to buy MAIA shares on news of the company’s new partnership with leading Chinese pharmaceutical firm BeiGene, positioning the duo…
Shares of micro-cap Achieve Life Sciences rose 5% on Tuesday, January 7, following the company’s announcement that its clinical trial for a smoking cessation drug successfully reached a critical milestone. This progress allows Achieve to file for regulatory approval and, if granted, begin commercial sales. Details On January 7, Achieve’s…
Shares of Acurx Pharmaceuticals, a small company specializing in the development of new antibiotics, fell 10% in after-hours trading on January 6 following the announcement of a planned secondary offering. The news dampened investor enthusiasm sparked earlier that day by regulatory approval of the company’s trial plan for its lead…
Shares of Citius Oncology, a lymphoma drug developer with a market capitalization of $110 million, jumped more than 18% on Monday, January 6, following the announcement that it had hired the investment bank Jefferies as a financial advisor to explore strategic alternatives. Details On Monday, Citius Oncology stock soared more…
In December, Carl Icahn, one of Wall Street’s most successful investors, increased his stake in nitrogen fertilizer producer CVR Partners to 38% by purchasing common units worth $2.4 million. The billionaire took an interest in the company after Donald Trump‘s victory in the U.S. presidential election. Known as an activist…
The Motley Fool has highlighted three stocks that investors should keep an eye on: two large caps and one small cap. It believes that all three have the potential to double investors’ money over the next decade but might appeal more to those willing to take on higher risk. AppLovin…
Freedom Broker has highlighted three small-cap companies worth investors’ attention. While operating across different industries, these companies share one common trait: their stock has a projected growth potential of at least 20% in 2025. Strawberry Fields REIT Strawberry Fields, a real estate investment trust (REIT) named after the famous 1967…
The percentage of employees whose workplace drug test showed signs of tampering has reached a 30-year high, warns Quest Diagnostics, one of the largest independent laboratories in the U.S. To deceive employers, test-takers substitute urine specimens, use synthetic alternatives, or mix samples with additives. The micro-cap Intelligent Bio Solutions (INBS),…
The S&P 600 index, which tracks small- and mid-cap companies, is expected to rise nearly 25% in 2025, outperforming the S&P 500, which represents the largest issuers, according to Freedom Broker. Analysts attribute this to increased appetite for riskier assets, including small-cap stocks, under Donald Trump’s presidency. Details Freedom Broker…
In 2024, small caps generally lagged behind their larger peers. However, several niche small-cap stocks experienced explosive growth, having soared more than 1,000%, according to Freedom Broker. Among them were genetic testing provider GeneDx, quantum computing pioneer Rigetti Computing, and Gen Z-focused banking service Dave. Let’s take a look at…
Bloomberg Intelligence has identified ten small- and mid-cap companies to watch carefully in 2025. These companies are poised for potential transformation, driven by catalysts such as leadership changes, asset sales or acquisitions, and plans for new products or services. The list also considers the potential impact of the incoming U.S.…
Shares of Grid Dynamics Holdings, a provider of technology consulting, platform and product engineering, and analytics services, surged nearly 10% in after-hours trading on Thursday, December 26. This came after the announcement that the company will join the S&P SmallCap 600 index on January 2. Details Grid Dynamics Holdings stock…
Quotes on SoundHound AI, a developer of voice assistants, has soared over 1,000% for the year to date, reports the Motley Fool. While this rally makes it one of the year’s best-performing stocks, the Motley Fool warns that the company may be overvalued. Details On Thursday, December 26, SoundHound AI…
Shares of Health In Tech, whose AI-based platform helps create personalized health insurance programs, surged to $5.50 per share on their first trading day on the Nasdaq, rising to 37.5% above the IPO price. Details Health In Tech stock opened at $4.92 per share on its first trading day, Tuesday,…
CNBC has put forward four small-cap stocks “for the stocking” going into 2025. These companies operate in different sectors but have a couple things in common: their shares have risen over 5% in the last month, yet they remain undervalued compared to their peers and have further upside, according to…
The head of Ark Invest, Cathie Wood, has recently increased her stake in 10x Genomics, among other small-cap names, reports the Motley Fool, which said the company has been “going in the wrong direction.” 10x Genomics, with a market capitalization of $1.78 billion, designs and manufactures gene sequencing technology. Details…
Fund managers at Royce, founded by Wall Street legend Chuck Royce and known for specializing in small- and mid-cap stocks, have shared investment ideas for 2025, including consumer durable names and discounters. Consumer durable products Royce fund managers are keen on companies that sell consumer durable products, such as RVs…
Over the first 11 months of the year, Almaty hotels reported more than $133 million in revenue, marking a 28% increase compared to the same period last year and a threefold surge compared to pre-pandemic levels. The increased financial indicators have attracted new investors to the industry, and Almaty’s hotel…
Shares of Canada’s Gatekeeper Systems, which offers intelligent video solutions designed to provide a safer transportation environment, plunged nearly 17% on Friday, December 20. While it reported record revenue for the 2024 fiscal year, the company also revealed a 34% decline in total comprehensive income. Details On Friday, Gatekeeper Systems…
Shares of AtlasClear, a micro-cap company building a platform to offer financial services to smaller and medium-sized businesses, fell almost 10% in after-hours trading on Friday, December 20, following the announcement of a 1-for-60 reverse stock split. Details In after-hours trading on Friday, AtlasClear Holdings stock tumbled almost 10% on…
Wedbush has initiated coverage of the “under-the-radar AI name” Innodata, rating it a “buy” with a target price 40% above the current market price. This gave a boost to Innodata stock, which jumped 16% before dropping almost 5% in premarket trading today, Friday, December 20. Details The target price for…
